AeroVironment, Inc. (AVAV)

Theseus Pharmaceuticals Revenue

In the fiscal year ending April 30, 2025, AeroVironment had annual revenue of $820.63M with 14.50% growth. AeroVironment had revenue of $275.05M in the quarter ending April 30, 2025, with 39.63% growth.

• Revenue (ttm): $820.63M
• Revenue Growth: +14.50%
• P/S Ratio: 8.88
• Revenue / Employee: $556,357
• Employees: 1,475
• Market Cap: 12.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Apr 30, 2025	820.63M	103.91M	14.50%
Apr 30, 2024	716.72M	176.18M	32.59%
Apr 30, 2023	540.54M	94.80M	21.27%
Apr 30, 2022	445.73M	50.82M	12.87%
Apr 30, 2021	394.91M	27.62M	7.52%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.